TALBOT CRESCENT LIMITED

Company number 13231142 ·

Dissolved

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

TALBOT CRESCENT LIMITED - Analysis Report

Company Number: 13231142

Analysis Date: 2025-07-29 14:14 UTC

Financial Health Assessment: TALBOT CRESCENT LIMITED


1. Financial Health Score: D

Explanation:
TALBOT CRESCENT LIMITED exhibits characteristics typical of a dormant company—minimal financial activity with nominal assets and equity. This results in a financial health score of D, reflecting an inactive operational state with limited financial data to signal growth or distress. Dormancy inherently implies the business is neither generating revenue nor incurring expenses, which in medical analogy is similar to a patient in a state of rest, with vital signs stable but no active metabolic processes.


2. Key Vital Signs

Metric Value Interpretation
Status Active Company is legally active, not dissolved or in liquidation.
Account Category Dormant No significant financial transactions; no operational revenue or expenses recorded.
Cash at Bank £1 Minimal cash balance, effectively negligible "circulatory" cash flow.
Net Assets £1 Equity equals share capital only; no accumulated reserves or retained earnings.
Share Capital £1 Very small capital base, likely nominal share issuance at formation.
Filing Status Accounts Overdue (as of 2024-11-30) Slight compliance risk due to overdue accounts filing (dormant accounts).
People with Significant Control Emex Estates London Limited (75-100% shares), Mr Khalid Alhashmi (significant influence) Clear ownership structure with a corporate controlling entity and an individual controller.

3. Diagnosis

TALBOT CRESCENT LIMITED is effectively a shell or holding entity with no active trading or business operations, as reflected by its dormant account filing status. The financial "vital signs" show a company in stasis—cash and net assets equal to the nominal £1 share capital, indicating no growth, no income, no expenses, and no operational complexity.

The overdue filing of dormant accounts is a mild symptom of administrative neglect, which if persistent could lead to regulatory penalties or reputational risk. However, there are no signs of financial distress such as negative equity, liabilities, or cash flow issues because the company has not engaged in transactions.

The ownership by Emex Estates London Limited and control by Mr Khalid Alhashmi suggests the company may be held for future use, asset holding, or internal structuring rather than active business.


4. Recommendations

  • Compliance Restoration: Immediate priority should be to file the overdue dormant accounts to avoid penalties or forced strike-off. Dormant accounts are simple to prepare but essential for maintaining good standing.
  • Review Purpose & Strategy: Confirm the strategic purpose of maintaining TALBOT CRESCENT LIMITED as a dormant entity. If intended for future activation or asset holding, ensure internal processes are in place to activate operational accounting and reporting when needed.
  • Monitor for Activation: Should the company move from dormancy to active trading, initiate robust financial controls, cash flow monitoring, and timely statutory filings to prevent symptoms of financial distress.
  • Maintain Minimal Administrative Activity: Even dormant companies require upkeep of statutory records and timely filing; consider appointing a compliance officer or external agent to oversee this.
  • Consider Capital Structure: With only £1 share capital, assess if this is adequate for intended future activities or if recapitalization is required.

Medical Analogy Summary

TALBOT CRESCENT LIMITED is currently in a state of "financial dormancy," akin to a patient in a medically induced coma—stable but inactive. The lack of operational "heartbeat" (transactions, cash flow) means there's no immediate risk of financial distress but also no signs of growth or vitality. The overdue filing is a mild "symptom" that should be treated swiftly to prevent regulatory "infection."


Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 29 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.